Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001390478-19-000023
Filing Date
2019-04-30
Accepted
2019-04-30 16:14:44
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sls-201904302019x10xka.htm 10-K/A 341885
2 EXHIBIT 10.46 sls-20190430x10xkaex1046.htm EX-10.46 140783
3 EXHIBIT 31.1 sls-20190430x10xkaex311.htm EX-31.1 5489
4 EXHIBIT 31.2 sls-20190430x10xkaex312.htm EX-31.2 5489
5 sellas-logoa05.jpg GRAPHIC 30719
  Complete submission text file 0001390478-19-000023.txt   537405
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33958 | Film No.: 19781890
SIC: 2834 Pharmaceutical Preparations